Universe Pharmaceuticals (UPC) Accounts Payables (2020 - 2026)
Universe Pharmaceuticals (UPC) posted Accounts Payables of $3.8 million for Q1 2026, up 124.84% sequentially from $1.7 million in Q3 2025.
Universe Pharmaceuticals (UPC) Accounts Payables (2020 - 2026) Analysis & Trends
Universe Pharmaceuticals has reported Accounts Payables for 7 years, with the latest figure at $3.8 million in Q1 2026.
- Quarterly Accounts Payables changed N/A year-over-year to $3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (changed N/A YoY) and the FY2025 annual result came in at $1.7 million, down 99.97% from the prior year.
- Accounts Payables advanced to $3.8 million in Q1 2026 per UPC's latest filing, from $1.7 million in the prior quarter.
- Over five years, Accounts Payables peaked at $4.9 billion in Q3 2024 and troughed at $1.7 million in Q3 2025.
- A 5-year average of $618.8 million and a median of $4.2 million in 2023 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables surged 107085.58% in 2024, then sank 99.97% in 2025.
- Over 5 years, Accounts Payables stood at $3.1 million in 2022, then jumped by 49.1% to $4.6 million in 2023, then soared by 107085.58% to $4.9 billion in 2024, then tumbled by 99.97% to $1.7 million in 2025, then surged by 124.84% to $3.8 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $3.8 million, $1.7 million, and $4.9 billion for Q1 2026, Q3 2025, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | Universe Pharmaceuticals | 3.04 Mn | -26.01 Mn | - | 3.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.75 Mn |
| Sep 30, 2025 | 1.67 Mn |
| Sep 30, 2024 | 4.91 Bn |
| Mar 31, 2024 | 7.76 Mn |
| Sep 30, 2023 | 4.59 Mn |
| Mar 31, 2023 | 11.24 Mn |
| Sep 30, 2022 | 3.08 Mn |
| Mar 31, 2022 | 3.65 Mn |
| Sep 30, 2021 | 5.31 Mn |
| Sep 30, 2020 | 2,691.19 Bn |